Surgical outcomes and long-term follow-up of patients with large ventricular septal defects with severe pulmonary arterial hypertension: single-center experience-Reference-Cited by-同舟云学术

Surgical outcomes and long-term follow-up of patients with large ventricular septal defects with severe pulmonary arterial hypertension: single-center experience

Published:2023-09-30 Issue:3 Volume:48 Page:1131-1138
ISSN:2602-3032
Container-title:Cukurova Medical Journal
language:
Short-container-title:

Author:

ORGUN Ali¹^ORCID,TOKEL Niyazi²^ORCID,ERDOĞAN İlkay²^ORCID,VARAN Birgül²^ORCID,ÖZKAN Murat²^ORCID,AŞLAMACI Mehmet Sait²^ORCID

Affiliation:

1. Sağlık Bilimleri Üniversitesi, Adana Şehir Eğitim ve Araştırma Hastanesi

2. BAŞKENT ÜNİVERSİTESİ, TIP FAKÜLTESİ

Abstract

Purpose: In this retrospective study, pediatric patients who underwent surgery for large ventricular septal defect (VSD) with severe pulmonary arterial hypertension (PAH) were evaluated in detail in terms of clinical characteristics, and long-term results, and reinterpreted with the current surgical criteria. Materials and Methods: Twenty-four patients who underwent surgery for large VSD due to PAH between 1994 and 2005 were included in the study. The patients were divided into two groups according to their pulmonary vascular resistance index (PVRI) and compared (group 1 with PVRI

Publisher

Cukurova Medical Journal

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference18 articles.

1. Noori NM, Teimouri A. Clinical course in children and adolescents with ventricular septal defect. Asian Cardiovasc Thorac Ann. 2019;27:529-34.

2. Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest. 2010;137:52-61.

3. Hu Z, Xie B, Zhai X, Liu J, Gu J, Wang X, et al. Midterm results of “treat and repair” for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension. J Thorac Dis. 2015;7:1165-73.

4. Hansmann G, Koestenberger M, Alastalo T-P, Apitz C, Austin ED, Bonnet D et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38:879–901.

5. Kozlik-Feldmann R, Hansmann G, Bonnet D, Schranz D, Apitz C, Michel-Behnke I. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016;102:42-8.